Skip to main content
. 2016 Oct 14;6(10):e012378. doi: 10.1136/bmjopen-2016-012378

Figure 4.

Figure 4

Rates of refractory disease according to current treatment and disease severity. CSU, chronic spontaneous urticaria; H2AH, H2-antihistamine; LTRA, leukotriene receptor antagonist; nsAH, non-sedating antihistamine.